Výsledky vyhledávání

Akademický článek

Prognostic Value of Tumor Tissue Up-regulated microRNAs in Clear Cell Renal Cell Carcinoma (ccRCC).

Autor: Pesta M; Department of Biology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.; Laboratory of Immunoanalysis, University Hospital in Pilsen, Pilsen, Czech Republic., Travnicek I; Department of Urology, University Hospital in Pilsen, Pilsen, Czech Republic., Kulda V; Department of Medical Chemistry and Biochemistry, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic; vlastimil.kulda@lfp.cuni.cz., Ostasov P; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Windrichova J; Laboratory of Immunoanalysis, University Hospital in Pilsen, Pilsen, Czech Republic.; Department of Medical Chemistry and Biochemistry, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Houfkova K; Department of Biology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Knizkova T; Department of Biology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Bendova B; Department of Urology, University Hospital in Pilsen, Pilsen, Czech Republic., Hes O; Department of Pathology, University Hospital in Pilsen, Pilsen, Czech Republic., Hora M; Department of Urology, University Hospital in Pilsen, Pilsen, Czech Republic., Topolcan O; Laboratory of Immunoanalysis, University Hospital in Pilsen, Pilsen, Czech Republic., Polivka J; Laboratory of Immunoanalysis, University Hospital in Pilsen, Pilsen, Czech Republic.; Department of Histology and Embryology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.

Publikováno v: In vivo (Athens, Greece) [In Vivo] 2024 Jul-Aug; Vol. 38 (4), pp. 1799-1805.

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience.

Autor: Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic; fialao@fnplzen.cz.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Hosek P; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Korunkova H; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Hora M; Department of Urology, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Kolar J; Department of Urology, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Windrichova J; Department of Immunochemistry Diagnostics, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Sorejs O; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Topolcan O; Department of Immunochemistry Diagnostics, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Travnicek I; Department of Urology, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Sedlackova H; Department of Urology, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Finek J; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.

Publikováno v: Anticancer research [Anticancer Res] 2023 Jan; Vol. 43 (1), pp. 463-471.

Zobrazit plný text záznamu

Akademický článek

BAI1 as a Prognostic Marker of Clear Cell Renal Cell Carcinoma (ccRCC).

Autor: Pesta M; Department of Biology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.; Laboratory of Immunoanalysis, University Hospital in Pilsen, Pilsen, Czech Republic., Travnicek I; Department of Urology, University Hospital in Pilsen, Pilsen, Czech Republic., Kulda V; Department of Medical Chemistry and Biochemistry, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic; vlastimil.kulda@lfp.cuni.cz., Windrichova J; Laboratory of Immunoanalysis, University Hospital in Pilsen, Pilsen, Czech Republic.; Department of Medical Chemistry and Biochemistry, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic., Rezackova H; Laboratory of Immunoanalysis, University Hospital in Pilsen, Pilsen, Czech Republic., Houfkova K; Department of Biology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic., Macanova T; Department of Biology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic., Bendova B; Department of Urology, University Hospital in Pilsen, Pilsen, Czech Republic., Nestorova A; Department of Medical Chemistry and Biochemistry, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic., Hes O; Department of Pathology, University Hospital in Pilsen, Pilsen, Czech Republic., Hora M; Department of Urology, University Hospital in Pilsen, Pilsen, Czech Republic., Topolcan O; Laboratory of Immunoanalysis, University Hospital in Pilsen, Pilsen, Czech Republic., Polivka J; Laboratory of Immunoanalysis, University Hospital in Pilsen, Pilsen, Czech Republic.; Department of Histology and Embryology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.

Publikováno v: Anticancer research [Anticancer Res] 2021 Sep; Vol. 41 (9), pp. 4463-4470.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání